Tilray Inc (NASDAQ:TLRY) Stock Position Raised by Marathon Trading Investment Management LLC

Marathon Trading Investment Management LLC increased its stake in Tilray Inc (NASDAQ:TLRY) by 52.4% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 76,501 shares of the company’s stock after acquiring an additional 26,301 shares during the quarter. Marathon Trading Investment Management LLC’s holdings in Tilray were worth $127,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of TLRY. Arizona State Retirement System boosted its position in shares of Tilray by 4.4% in the second quarter. Arizona State Retirement System now owns 216,693 shares of the company’s stock worth $360,000 after buying an additional 9,171 shares during the period. CapWealth Advisors LLC boosted its position in Tilray by 12.5% during the 1st quarter. CapWealth Advisors LLC now owns 90,000 shares of the company’s stock worth $222,000 after acquiring an additional 10,000 shares during the period. Simplicity Wealth LLC purchased a new position in Tilray during the 1st quarter valued at about $28,000. RPO LLC acquired a new position in shares of Tilray in the 4th quarter valued at about $28,000. Finally, Private Advisor Group LLC lifted its position in shares of Tilray by 7.3% in the first quarter. Private Advisor Group LLC now owns 175,845 shares of the company’s stock worth $434,000 after purchasing an additional 12,021 shares in the last quarter. 9.35% of the stock is owned by institutional investors and hedge funds.

Tilray Stock Performance

TLRY stock opened at $1.80 on Thursday. The stock has a market cap of $1.52 billion, a P/E ratio of -4.09 and a beta of 2.13. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.42 and a current ratio of 2.27. The firm has a 50 day simple moving average of $1.82 and a 200 day simple moving average of $1.87. Tilray Inc has a 52 week low of $1.50 and a 52 week high of $2.97.

Tilray (NASDAQ:TLRY) last posted its quarterly earnings results on Monday, July 29th. The company reported ($0.04) EPS for the quarter, missing the consensus estimate of ($0.02) by ($0.02). Tilray had a negative net margin of 30.26% and a negative return on equity of 2.63%. The company had revenue of $229.90 million for the quarter, compared to analysts’ expectations of $226.20 million. During the same quarter in the prior year, the firm earned ($0.15) earnings per share. The company’s revenue was up 24.8% on a year-over-year basis. Research analysts anticipate that Tilray Inc will post -0.16 earnings per share for the current fiscal year.

Tilray Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.